Our Pipeline

Medicines that matter.

Our platform enables us to determine what biology to prosecute with unprecedented confidence. Based on these insights, we let the biology drive how we treat a disease – operating in an agnostic manner to modality. We develop medicines to clinical value inflection points – either via de-novo discovery or in-licensed.

Our pipeline spans bone, cardio-renal, dermatology and rheumatology.

Development pipeline
Type	Indication	Development stage
Internal		lead op phase
	Osteoporosis Over 45 million patients across the US, Europe and Japan. Affects one in two women and one in four men over 50. An inherited disease with over 2,000 gene loci identified to date. High translational fidelity from patient to lab to patient. Discovery driven by Relation’s proprietary bone atlas, Osteomics. Relation's dominant position in OP. We have built the world’s largest full-omic human bone biology atlas. This has allowed us to combine the atlas with insights from population genetics to generate multiple novel first-in-class programmes for OP, in addition to rationally designed OP projects that leverage known biology.
	Chronic kidney disease	platform validation phase
Partnered	Skin fibrosis GSK	end of platform validation phase
	Atopic diseases Novartis
	Osteoarthritis GSK	platform validation phase
	Project Morgan GSK	platform validation phase

Internal

Osteoporosis

Over 45 million patients across the US, Europe and Japan.
Affects one in two women and one in four men over 50.
An inherited disease with over 2,000 gene loci identified to date.
High translational fidelity from patient to lab to patient.
Discovery driven by Relation’s proprietary bone atlas, Osteomics.

Relation's dominant position in OP.

We have built the world’s largest full-omic human bone biology atlas. This has allowed us to combine the atlas with insights from population genetics to generate multiple novel first-in-class programmes for OP, in addition to rationally designed OP projects that leverage known biology.

Chronic kidney disease

Partnered

Skin fibrosis GSK

Atopic diseases Novartis

Osteoarthritis GSK

Project Morgan GSK

Our team

World-class drug developers, computational scientists and entrepreneurs, with experience across biopharma and tech.

Meet our team.